Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Janus Henderson Group PLC reported a 13.70% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 13.70% stake in Lexeo Therapeutics, Inc., 4,557,920 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 13.70%
- Shares
- 4,557,920
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.70% | 4,557,920 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.10% | 2,683,874 |
Source
Related
- Lexeo Therapeutics, Inc.
- Janus Henderson Group PLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Dec 8, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026